Results 1 to 10 of about 219 (67)

Evaluating the diagnostic accuracy of QIAreach QuantiFERON-TB compared to QuantiFERON-TB Gold Plus for tuberculosis: a systematic review and meta-analysis

Scientific Reports
Accurate tuberculosis (TB) diagnosis remains challenging, especially in resource-limited settings. This study aims to assess the diagnostic performance of the QIAreach QuantiFERON-TB (QFT) assay, with a specific focus on comparing its diagnostic ...
Shima Mahmoudi, Sadra Nourazar
doaj   +2 more sources

QuantiFERON-TB Gold PLUS versus QuantiFERON-TB Gold In-Tube test for diagnosing tuberculosis infection [PDF]

The Korean Journal of Internal Medicine, 2020
Background/Aims QuantiFERON-TB Gold PLUS (QFT-PLUS) was developed as a new version of the interferon-γ (IFN-γ) release assay that contains an extra antigen tube to elicit a CD8+ T-cell response in addition to a CD4+ T-cell response.
Soo Han Kim, Kyung-Wook Jo, Tae Sun Shim
doaj   +1 more source

Role of interferon gamma release assay in the diagnosis and management of Mycobacterium tuberculosis-associated uveitis: a review

BMJ Open Ophthalmology, 2021
Tuberculosis (TB)-associated uveitis is a common cause of infectious uveitis in the developing world. Diagnosis of TB uveitis remains a challenge. The role of interferon gamma release assays (IGRAs) is uncertain.
M A Rehman Siddiqui, Muhammad Irfan, Samra Rahman   +2 more
doaj   +1 more source

Differential Diagnosis of Latent Tuberculosis Infection and Active Tuberculosis: A Key to a Successful Tuberculosis Control Strategy

Frontiers in Microbiology, 2021
As an ancient infectious disease, tuberculosis (TB) is still the leading cause of death from a single infectious agent worldwide. Latent TB infection (LTBI) has been recognized as the largest source of new TB cases and is one of the biggest obstacles to ...
Wenping Gong, Xueqiong Wu
doaj   +1 more source

First clinical evaluation of the QIAreachTM QuantiFERON-TB for tuberculosis infection and active pulmonary disease

Pulmonology, 2022
Objective 1) to compare the QIAreachTM QuantiFERON-TB (QIAreach QFT) vs. QuantiFERON®-TB Gold Plus assay (QFT-Plus) to detect tuberculosis (TB) infection; 2) to evaluate diagnostic sensitivity of QIAreach QFT using active TB as surrogate for TB infection;
K. Fukushima, K. Akagi, A. Kondo, T. Kubo, N. Sakamoto, H. Mukae   +5 more
doaj   +3 more sources

Performance evaluation of newly developed fluorescence immunoassay-based interferon-gamma release assay for the diagnosis of latent tuberculosis infection in healthcare workers

Journal of Microbiology, Immunology and Infection, 2022
The ichroma™ IGRA-TB (Boditech Med Inc., Chuncheon, Republic of Korea) is an automated fluorescent immunoassay-based point-of-care interferon-gamma release assay for detecting latent tuberculosis infection.
Oh Joo Kweon, Yong Kwan Lim, Hye Ryoun Kim, Tae-Hyoung Kim, Mi-Kyung Lee   +4 more
doaj   +1 more source

Comparative Study between Polymerase Chain Reaction and Different Rapid Tests for Detection of Mycobacterium Infection. [PDF]

Journal of Bioscience and Applied Research, 2016
The objective of this work is to reach a sensitive and rapid method for the laboratory diagnosis of active tuberculosis disease in patients and latent TB infection in household contacts and healthy community controls.
Elarabany N. F, Abdallah, A. E., Abdallah, G. A., Salah A.   +3 more
doaj   +1 more source

LIOFeron®TB/LTBI: A novel and reliable test for LTBI and tuberculosis

International Journal of Infectious Diseases, 2020
Objectives: High accuracy diagnostic screening tests for tuberculosis (TB) are required to improve the diagnosis of both active TB and latent Mycobacterium tuberculosis (MTB) infection (LTBI).
Chiara Della Bella, Michele Spinicci, Heba F. Mustafa Alnwaisri, Filippo Bartalesi, Simona Tapinassi, Jessica Mencarini, Marisa Benagiano, Alessia Grassi, Sofia D’Elios, Arianna Troilo, Arailym Abilbayeva, Dinara Kuashova, Elmira Bitanova, Anel Tarabayeva, Eduard Arkadievich Shuralev, Alessandro Bartoloni, Mario Milco D’Elios   +16 more
doaj   +1 more source

Evaluation of the performance of QuantiFERON®-TB Gold plus test in active tuberculosis patients

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2021
The aim was to evaluate the sensitivity and the possible factors affecting the sensitivity of the QuantiFERON®-TB Gold Plus (QFT-Plus) assay in culture-positive active TB (Tuberculosis) patients, to investigate the possible causes of negative and ...
Cengiz Çavuşoğlu, Melike Yaşar-Duman, Mehmet Sezai Taşbakan, Meltem Işıkgöz-Taşbakan, Mehmet Nurullah Orman   +4 more
doaj   +1 more source

Comparing the diagnostic performance of QuantiFERON-TB Gold Plus with QFT-GIT, T-SPOT.TB and TST: a systematic review and meta-analysis

BMC Infectious Diseases, 2023
Background QuantiFERON-TB Gold Plus (QFT-Plus) is an important test that has emerged in recent years for detecting TB infection. We conducted a review to compare the sensitivity, specificity and positive rate of QFT-Plus with that of QuantiFERON-TB Gold ...
Yu Zhang, Guozhong Zhou, Wei Shi, Weili Shi, Meijun Hu, Defu Kong, Rong Long, Jian He, Nan Chen   +8 more
doaj   +1 more source